Frances A Tsai, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 485 Route 1 S, Building A, Iselin, NJ 08830 Phone: 732-750-0400 |
Dr. Christopher J Quinn, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 485 Route 1, Bldg A, Iselin, NJ 08830 Phone: 732-750-0400 Fax: 732-750-1507 |
Natalie Nguyen Optometrist Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 South, Building A, Omni Eye Services, Iselin, NJ 08830 Phone: 732-750-0400 |
Dr. Pooja Kadakia, OD Optometrist Medicare: Medicare Enrolled Practice Location: 485 Us-1, Iselin, NJ 08830 Phone: 732-750-0400 |
Poonam K Bhavsar Optometrist Medicare: Not Enrolled in Medicare Practice Location: 485 Route 1 South, Building A, Iselin, NJ 08830 Phone: 732-750-0400 |
Chelsea Kleen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 S, Iselin, NJ 08830 Phone: 732-750-0400 Fax: 732-602-0749 |
Mason Munn, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 S, Iselin, NJ 08830 Phone: 908-268-1596 |
Dr. Samantha Sanborn, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 485 Route 1 South, Building A, Iselin, NJ 08830 Phone: 732-750-0400 |
Nazreen A Esack, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 S, Building A, Iselin, NJ 08830 Phone: 732-750-0400 Fax: 732-602-0749 |
George W Veliky, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 S, Bldg A, Iselin, NJ 08830 Phone: 732-750-0400 Fax: 732-750-1507 |
Dr. Lauren Kitzhoffer Mullen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 S, Bldg A, Iselin, NJ 08830 Phone: 732-750-0400 Fax: 732-602-0749 |
Jessica Garden, OPTOMETRIST Optometrist Medicare: Accepting Medicare Assignments Practice Location: 485 Route 1 S Bldg A, Iselin, NJ 08830 Phone: 732-750-0400 |
News Archive
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings obtained during their first human clinical trial in the form of two oral presentations at The Eye and the Chip 2010 Annual Meeting in Detroit, Mich.
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the Board of Appeals of the European Patent Office (EPO) has ruled that claims of the Kreutzer-Limmer '945 (EP 1214945) patent meet needed requirements under European patent law. The '945 patent comprises broad claims covering the length and certain structural requirements for siRNAs that are important for advancement of RNAi therapeutics.
A newly discovered virus may be responsible for many respiratory tract illnesses in infants and children, and may be associated with an important multi-organ disease whose cause has remained a mystery for decades, according to articles in the Feb. 15 issue of The Journal of Infectious Diseases, now available online.
› Verified 2 days ago